Kotaro Itohara

Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case–control study

Keiko Ikuta, Shunsaku Nakagawa, Kenji Momo et al. · BMJ Open · 2021 · 30 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +14

Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder

Yuki Shigetsura, Satoshi Imai, Hiroki Endo et al. · Clinical Neuropharmacology · 2022 · 27 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

Antibiotic-induced microbiome depletion alters renal glucose metabolism and exacerbates renal injury after ischemia-reperfusion injury in mice

Yuika Osada, Shunsaku Nakagawa, Kanako Ishibe et al. · American Journal of Physiology-Renal Physiology · 2021 · 22 citations

Life Sciences, Microbiology, Pharmacology +15

Population pharmacokinetic modeling of GS‐441524, the active metabolite of remdesivir, in Japanese COVID‐19 patients with renal dysfunction

Asami Sukeishi, Kotaro Itohara, Atsushi Yonezawa et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 21 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Association between time in therapeutic range of tacrolimus blood concentration and acute rejection within the first three months after lung transplantation

Y. Katada, Shunsaku Nakagawa, Kotaro Itohara et al. · Journal of Pharmaceutical Health Care and Sciences · 2022 · 20 citations · Full text

Medicine, Pharmacology, Surgery +17